Wednesday, June 24, 2020 CCTG is pleased to announce that the 2020 CCTG Phase III Team Award for Intergroup-Led trials has been awarded to the Princess Margaret Cancer Centre CE.8 trial team based on the centre's accrual metrics both overall and for this past year, local activation timelines, and compliance metrics. The team members include: Warren Mason, Normand J. Laperriere, Barbara Ann Millar, David Shultz, Derek Tsang, Ronald Ramos, Seth Climans, Stephanie Baker, On Yee Jones, Lynette Francis, Risho Yogananthan, Stephanie DeLuca, Anjie Yang, Irum Mahmood, Divyalakshmi Babu, Christina Cater, Kristin Dunlop, Sarah Eley, Shirley Ho, Sam Park, Rosa Pezzulli, Eamay Apostol, Moya Brown, Chermay Espino, Jermain Joseph, Hema Mohabir, Kenneth Mojica, Madeline Philips, Kathie Witkowski, Jessy Abed, Benoit Guibord, Vanessa Speers, Nanthini Tharahan, Rohini Gosai "It is with sincere thanks that we accept the Phase III Team Award from CCTG for study CE.8. From study start-up to implementation, it takes the dedication and hard work of the whole team to run a successful study. We are pleased to be honored with this award and acknowledged at this time. A special recognition to the patients for participating in this innovative research study," says Dr. Mason. Please join everyone at CCTG in congratulating this team for their efforts and dedication to the success of clinical trials. For more information about CE.8, please visit https://www.ctg.queensu.ca/trials/brain/ce8/ For more information on the CCTG Awards and the 2020 honorees, please visit https://www.ctg.queensu.ca/public/recognition-awards.
